PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, China.\', \'Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.\', \'Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.\', \'School of Medicine, Baylor College of Medicine, Houston, TX, USA.\', \'Department of Gynecology and Obstetrics, Guangdong Women and Children Hospital, Guangzhou, China.\', \'Department of Biochemistry, School of Life Sciences, Central South University, Changsha, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jcmm.16385
?:hasPublicationType
?:journal
  • Journal of cellular and molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 33609069
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.647
?:rankingScore_hIndex
  • 108
is ?:relation_isRelatedTo_publication of
?:title
  • Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all